person · Reporting owner
Cook Robert Christopher
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| FILANA THERAPEUTICS, INC.SAVA · Entity 7294 | Chief Operating & Legal Office | September 30, 2025 | October 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
FILANA THERAPEUTICS, INC.
Report date September 30, 2025 · Filed October 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,725 |
Reported balance
After 2025-09-30 transaction · row 1
1 source rowRow 1 · 2025-09-30 · Purchase · Acquired 13,725 · Balance 13,725 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2025 Filed Oct 2, 2025 20:44 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | PurchaseCommon Stock | 13,725 | $2.91 | $39,939.75 |
DisclosureSEC source: 0001437749-25-030348 · rdgdoc.xml · nonDerivative · entry 1 Cook Robert Christopher · CIK 0001952028 · Chief Operating & Legal Office 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,725 Read SEC document |
| April 17, 2025 Filed Apr 21, 2025 20:43 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.44 | $0.00 |
DisclosureSEC source: 0001437749-25-012545 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · Chief Operating & Legal Office 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-04-17 F1 · derivative.exercise_date: The stock option vests in four equal annual installments (25% each year) with the initial 25% vesting on April 17, 2026. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 21:43 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $26.91 | $0.00 |
DisclosureSEC source: 0001437749-24-028782 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2034-09-06 F1 · derivative.exercise_date: The stock option vests over 2 years, with 50% cliff vesting 1-year after grant date and the remaining 50% cliff vesting 2-years after grant date. Read SEC document |
| May 20, 2024 Filed May 22, 2024 20:52 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $22.10 | $0.00 |
DisclosureSEC source: 0001437749-24-018023 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2034-05-20 F1 · derivative.exercise_date: The stock option vests over four (4) years at a rate of 1/48th each full month. Read SEC document |
| October 03, 2023 Filed Oct 4, 2023 22:33 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $17.54 | $0.00 |
DisclosureSEC source: 0001437749-23-027700 · rdgdoc.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2033-10-03 F1 · derivative.exercise_date: The stock option vests over three (3) years at a rate of 1/36th each month. Read SEC document |
| October 28, 2022 Filed Oct 31, 2022 20:54 UTC | FILANA THERAPEUTICS, INC. SAVA · Entity 7294 | GrantEmployee Stock Option (right to buy) · Derivative | 100,000 | $36.76 Strike: $36.76 | $3,676,000.00 |
DisclosureSEC source: 0001069530-22-000054 · certent-form4.xml · derivative · entry 1 Cook Robert Christopher · CIK 0001952028 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-10-28 F1 · derivative.exercise_date: Stock options vest over a four (4) year period at a rate of 1/48th per month. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.